![]() | |
Names | |
---|---|
IUPAC name 6-[1-Hydroxy-2-[(2-methyl-4-phenylbutan-2-yl)amino]ethyl]-3,4-dihydro-1H-quinolin-2-one | |
Other names Brefanolol | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider | |
UNII | |
| |
| |
Properties | |
C22H28N2O2 | |
Molar mass | 352.478 g·mol−1 |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
Brefonalol is abeta-adrenergic antagonist that reduces heart frequency and blood pressure anddilates blood vessels. It has been studied in around 1990,[1] but is not known to be marketed as of 2021[update].
![]() | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byexpanding it. |